Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 5/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10585526 | 1.00 | ALDH1A1 (0.39) | ALDH1A1LMNAOR51E2ACLYCPT2 | |
| SCHEMBL7155871 | 1.00 | ALDH1A1 (0.39) | ALDH1A1LMNAOR51E2ACLYCPT2 | |
| SCHEMBL31620636 | 0.83 | ALDH1A1 (0.40) | ALDH1A1OR51E2ACLYCPT2 | |
| SCHEMBL6893674 | 0.82 | ALDH1A1 (0.58) | ALDH1A1ACLYCPT2 | |
| SCHEMBL31674430 | 0.81 | OR51E2 (0.46) | ALDH1A1OR51E2ACLYCPT2 | |
| SCHEMBL8408051 | 0.79 | ALDH1A1 (0.37) | ALDH1A1ACLYCPT2 | |
| SCHEMBL2030122 | 0.76 | — | — | |
| SCHEMBL2363134 | 0.76 | ACACB (0.38) | ALDH1A1ACLY | |
| SCHEMBL9701723 | 0.75 | ALDH1A1 (0.40) | ALDH1A1LMNAOR51E2ACLYCPT2 | |
| SCHEMBL29285410 | 0.75 | ALDH1A1 (0.40) | ALDH1A1LMNAOR51E2ACLYCPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| WO-2024191956-A2 | MALODOR COUNTERACTING COMPOSITION | SKYESTER, INC. (US) | 2024-09-19 | — | — | WO | claimed |
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | BATTELLE MEMORIAL INSTITUTE (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250381163-A1 | Chelating Agents for Use in Cancer Therapy | PLECO THERAPEUTICS B V (NL) | 2025-12-18 | — | — | US | disclosed |
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | disclosed |
| US-12377113-B2 | Glycan therapeutic compositions and related methods thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| US-12357546-B2 | Sprayable compositions containing oil-in-water emulsions containing submicron hydrophobic agents and methods of use thereof | Leading Edge Innovations, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| EP-4547281-A1 | IMPROVED DOWNREGULATION OF HISTONE CYTOTOXICITY BY COMPLEX OF NEGATIVELY CHARGED POLYSACCHARIDE AND PROTEASE | Universiteit Maastricht (NL) | 2025-05-07 | — | — | EP | disclosed |
| WO-2025089964-A1 | METHODS FOR TESTING ACTIVE COMPOUNDS IN MODELS WITH ELEVATED HEAVY METAL ACCUMULATION | PLECO THERAPEUTICS B.V. (NL) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025088316-A1 | NOVEL COMPOSITIONS | ARECOR LIMITED (GB) | 2025-05-01 | — | — | WO | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | ERCC4, ERCC2, XPA | ALDH1A1 3727/4885LMNA 556/4885OR51E2 2279/4885 |
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | RNASEH1, ACE2, DDX42 | ALDH1A1 1924/4885LMNA 3512/4885OR51E2 1894/4885 |
| US-12357546-B2 | Sprayable compositions containing oil-in-water emulsions containing submicron hydrophobic agents and methods of use thereof | LIPA, MGLL, SGMS2 | ALDH1A1 4067/4885LMNA 1826/4885OR51E2 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.